Takeda Pharmaceutical Co Ltd (TAK)
13.62
+0.06
(+0.41%)
USD |
NYSE |
Nov 15, 16:00
13.62
0.00 (0.00%)
After-Hours: 19:55
Takeda Pharmaceutical Debt to Equity Ratio: 0.7299 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.7299 |
| June 30, 2024 | 0.7028 |
| March 31, 2024 | 0.666 |
| December 31, 2023 | 0.6918 |
| September 30, 2023 | 0.6618 |
| June 30, 2023 | 0.6859 |
| March 31, 2023 | 0.6897 |
| December 31, 2022 | 0.6941 |
| September 30, 2022 | 0.7056 |
| June 30, 2022 | 0.7286 |
| March 31, 2022 | 0.7646 |
| December 31, 2021 | 0.8168 |
| September 30, 2021 | 0.7948 |
| June 30, 2021 | 0.8411 |
| March 31, 2021 | 0.8961 |
| December 31, 2020 | 1.025 |
| September 30, 2020 | 1.053 |
| June 30, 2020 | 1.083 |
| March 31, 2020 | 1.078 |
| December 31, 2019 | 1.072 |
| September 30, 2019 | 1.033 |
| June 30, 2019 | 1.161 |
| March 31, 2019 | 1.110 |
| December 31, 2018 | 1.250 |
| September 30, 2018 | 0.4614 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.4869 |
| March 31, 2018 | 0.4935 |
| December 31, 2017 | 0.5386 |
| September 30, 2017 | 0.5453 |
| June 30, 2017 | 0.5683 |
| March 31, 2017 | 0.6044 |
| December 31, 2016 | 0.4925 |
| September 30, 2016 | 0.5229 |
| June 30, 2016 | 0.5277 |
| March 31, 2016 | 0.3942 |
| December 31, 2015 | 0.3479 |
| September 30, 2015 | 0.344 |
| June 30, 2015 | 0.3386 |
| March 31, 2015 | 0.3413 |
| December 31, 2014 | 0.3646 |
| September 30, 2014 | 0.3572 |
| June 30, 2014 | 0.3583 |
| March 31, 2014 | 0.3481 |
| December 31, 2013 | 0.3322 |
| September 30, 2013 | 0.3468 |
| June 30, 2013 | 0.2449 |
| March 31, 2013 | 0.2571 |
| December 31, 2012 | 0.2628 |
| September 30, 2012 | 0.2833 |
| June 30, 2012 | 0.287 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.6618
Minimum
Sep 2023
1.083
Maximum
Jun 2020
0.819
Average
0.7472
Median
Debt to Equity Ratio Benchmarks
| HUTCHMED (China) Ltd | 0.1109 |
| Astellas Pharma Inc | 0.5765 |
| Nxera Pharma Co Ltd | 0.9607 |
| PeptiDream Inc | 0.3561 |
| Healios KK | 1.863 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 102.04B |
| Total Liabilities (Quarterly) | 53.58B |
| Shareholders Equity (Quarterly) | 48.46B |
| Current Ratio | 1.279 |
| Net Debt Paydown Yield | -1.15% |